Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antiestrogenic effects of Sch-57068 in female reproductive organs examined in detail in rats

June 26, 2002

Introgen's Advexin receives proprietary name approval from FDA

June 26, 2002

Potent HDAC inhibitors identified at Abbott with submicromolar antitumor activity

June 26, 2002

Oral retinoid for CTCL introduced in Germany

June 26, 2002

BioVex commences phase I trial of OncoVEX GM-CSF for solid tumors

June 26, 2002

Novel antitumor naphthyridines identified by Dainippon

June 25, 2002

BioCryst describes PNP inhibitors with potential in cancer therapy

June 25, 2002

Bioenvision initiates clofarabine clinical program

June 25, 2002

PhotoCure subscribes for shares in Anticancer Therapeutic Inventions

June 25, 2002

CYP1B1 converts resveratrol to the antileukemic agent piceatannol

June 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...